Effect of Withania somnifera on CTL activity

Area of Science:

• Immunology
• Pharmacology
• Cancer Research

Background:

• Cytotoxic T lymphocytes (CTLs) are crucial for cell-mediated immunity and tumor surveillance.
• Withania somnifera (Ashwagandha) is an adaptogenic herb with a history of medicinal use.
• Investigating natural compounds for immunomodulatory and anti-tumor properties is an active area of research.

Purpose of the Study:

• To evaluate the stimulatory effect of Withania somnifera on cytotoxic T lymphocytes (CTLs).
• To assess the impact of Withania somnifera on tumor growth and survival rates in a mouse model.
• To determine the efficacy of Withania somnifera in enhancing CTL-mediated anti-tumor immunity.

Main Methods:

• Winn's Neutralization assay using CTL-sensitive EL4 thymoma cells as targets in Balb/C mice.
• In vivo and in vitro assessment of CTL production following Withania somnifera administration.
• Monitoring animal survival time and calculating percentage increase in life span (% ILS) across different treatment groups.

Main Results:

• Withania somnifera significantly increased CTL production both in vivo and in vitro.
• Treatment with Withania somnifera extract led to a substantial increase in the survival time of tumor-bearing mice, with % ILS ranging from 114.28% to 177.27% depending on the treatment protocol.
• Enhanced survival rates were observed when effector cells were generated from Withania somnifera-treated animals or when mixed lymphocyte cultures were supplemented with the extract.

Conclusions:

• Withania somnifera effectively stimulates the generation and activity of cytotoxic T lymphocytes.
• The findings suggest that Withania somnifera possesses anti-tumor properties, likely mediated through the enhancement of cell-mediated immunity.
• Further research into Withania somnifera as a potential adjunct therapy for cancer is warranted.